A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML
DOI:
10.1016/j.drup.2025.101242
Publication Date:
2025-03-31T19:22:29Z
AUTHORS (18)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (74)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....